Uptake and disparities in tuberculosis screening using urine-lipoarabinomannan among patients with advanced human immunodeficiency virus-disease in Africa: A systematic review

doi:10.5501/wjv.v14.i3.107214

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 3

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (11)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-2) series, Tables (1-1) series.

Item

Count

PDF

HTML

Figures (1-2)

Tables (1-1)

Sum=10

Sep 25, 2025 (publication date) through Sep 25, 2025

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Virology

ISSN

2220-3249

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Systematic Reviews

World J Virol. Sep 25, 2025; 14(3): 107214
Published online Sep 25, 2025. doi: 10.5501/wjv.v14.i3.107214

Open in New Tab Full Size Figure Download Figure

Figure 1 PRISMA flow diagram of the included studies for meta-analysis of uptake and disparities in tuberculosis screening using urine lipoarabinomannan in advanced human immunodeficiency virus disease in Africa.

Open in New Tab Full Size Figure Download Figure

Figure 2 The situation of late-stage human immunodeficiency virus patients in Africa. A: Prevalence of tuberculosis (TB) testing uptake among patients with advanced human immunodeficiency virus (HIV) disease in Africa; B: Prevalence of TB among patients with advanced HIV disease in Africa; C: Prevalence of mortality among patients with advanced HIV disease diagnosed with Tuberculosis in Africa; D: Prevalence of TB treatment initiations among patients with advanced HIV disease diagnosed with Tuberculosis in Africa.

Citation: Moshi L, Bakari HM, Mbishi JV, Ally ZM, Mbwana MS, Ally HM, Musoke R, Salim SM, Karia MF, Karia LF, Fussi HF, Mustafa AO, El-lmam IA, Ramadhani HO. Uptake and disparities in tuberculosis screening using urine-lipoarabinomannan among patients with advanced human immunodeficiency virus-disease in Africa: A systematic review. World J Virol 2025; 14(3): 107214
URL: https://www.wjgnet.com/2220-3249/full/v14/i3/107214.htm
DOI: https://dx.doi.org/10.5501/wjv.v14.i3.107214